Heart Failure With Preserved Ejection Fraction Across the Spectrum of Body Mass Index: Hemodynamic and Echocardiographic Characteristics and Outcomes

The research reported in this publication was conducted by PCORnet. PCORnet has been developed with funding from the PCORI (Patient-Centered Outcomes Research Institute) . The statements presented in this publication are solely the responsibility of the authors and do not necessarily represent the views of organizations participating in, collaborating with, or funding PCORnet or PCORI. Dr Harrington has acted as a consultant for Novo Nordisk. Dr Fudim was supported by the NIH (National Institute of Health) , Alleviant, Gradient, Reprieve, Sardocor, and the Doris Duke Foundation; and is a consultant and/or has ownership interest in Abbott, Acorai, Ajax, Alio Health, Alleviant, Artha, Astellas, Audicor, Axon Therapies, BodyGuide, Bodyport, Boston Scientific, Broadview, Cadence, Cardiosense, Cardioflow, Clinical Accelerator, CVRx, Daxor, Edwards Lifesciences, Echosens, EKO, Endotronix, Feldschuh Foundation, Fire1, FutureCardia, Gradient, Hatteras, HemodynamiQ, Impulse Dynamics, ISHI, Lumina Health, Medtronic, Novo Nordisk, NucleusRx, Omega, Orchestra, Parasym, Pharmacosmos, Presidio, Procyreon, Proton Intelligence, Puzzle, ReCor, Scirent, SCPharma, Shifamed, Splendo, Summacor, SyMap, Terumo, Vascular Dynamics, Vironix, Viscardia, and ZOLL. Dr Peters has received honoraria from Cytokinetics; has received research grants from the NHLBI (National Heart, Lung, and Blood Institute) , American Heart Association, Amgen, Bayer, Bristol Myers Squibb, Novartis, Daxor, Merck, Cytokinetics, and CSL Behring; has acted as a consultant to Novartis,Amgen, BMS, Cytokinetics, Innolife, Medtronic, Cardionomic, Boehringer Ingelheim, American Regent, Abbott, AstraZeneca, Regeneron, Reprieve, Myovant, Sequana, Windtree, Rocket Pharma, and Whiteswell; and has served on clinical endpoint committees/data safety monitoring boards for Amgen, Merck, Medtronic, EBR Systems, V-Wave, and LivaNova. Dr Jones has received research grants from the Agency for Healthcare Research and Quality, Boehringer Ingelheim, Doris Duke Foundation, NIH, and PCORI; and honoraria/other from Bayer, Bristol Myers Squibb, and Janssen Pharmaceuticals. Dr Steinberg has received salary support from the NIH/NHLBI (grant numbers R56HL168264, R21HL172288, and 1R01HL177105) ; research support from Abbott, Boston Scientific, Biosense Webster, Sanofi, and AltaThera; and consulting to Sanofi, Bayer, Boston Scientific, Element Science, Milestone, and AltaThera. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.r Amgen, BMS, Cytokinetics, Innolife, Medtronic, Cardionomic, Boehringer Ingelheim, American Regent, Abbott, AstraZeneca, Regeneron, Reprieve, Myovant, Sequana, Windtree, Rocket Pharma, and Whiteswell; and has served on clinical endpoint committees/data safety monitoring boards for Amgen, Merck, Medtronic, EBR Systems, V-Wave, and LivaNova. Dr Jones has received research grants from the Agency for Healthcare Research and Quality, Boehringer Ingelheim, Doris Duke Foundation, NIH, and PCORI; and honoraria/other from Bayer, Bristol Myers Squibb, and Janssen Pharmaceuticals. Dr Steinberg has received salary support from the NIH/NHLBI (grant numbers R56HL168264, R21HL172288, and 1R01HL177105) ; research support from Abbott, Boston Scientific, Biosense Webster, Sanofi, and AltaThera; and consulting to Sanofi, Bayer, Boston Scientific, Element Science, Milestone, and AltaThera. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.